• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

Mobile ID World

Mobile ID World

Identification Revolution

  • Mobile ID
    • What Is Mobile ID?
    • Identity Associations
    • Premier Partners
    • FAQ
  • News
  • Solutions
    • Behavioral
    • Facial Recognition
    • Fingerprint Biometrics
    • Iris Biometrics
    • Second Factor
    • Smart Cards
    • Smartphones
    • Vital
    • Voice
    • Wearable Tech
    • Other
  • Applications
    • Access Control
    • Cloud Technology
    • Commerce
    • Enterprise
    • Healthcare
    • Identification
    • Internet of Things
    • Law Enforcement
    • Strong Online Authentication
  • Exclusive
    • Interviews
    • Featured Articles
    • Podcasts
  • Companies
  • Events

COVID-19 Vaccine Trial Gets Support from Biometric Wristband

August 17, 2020

G42 Healthcare has announced a partnership with Boston-based wearable tech firm WHOOP that will result in volunteers participating in Phase III trials of an inactivated COVID-19 vaccine having the option to wear the WHOOP Strap 3.0 biometric smart band to measure various biometric data points while trialing the vaccine in what is being called The Whoop4Humanity initiative.

G42 Healthcare Brings Biometric WHOOP Bands Into COVID-19 Vaccine Trial

“As a digital business, this new partnership is a logical extension of the highly-advanced AI and super computer solutions we are already using in the trials process,” said G42 Heathcare CEO Ashish Koshy. “New volunteers will be invited to engage with the technology developed by WHOOP to enhance their individual volunteer experience and contribute to the advanced research involved in these sophisticated trials.”

The WHOOP Strap 3.0 will allow trial participants who choose to wear the device to track their daily heart rate, respiratory rate, sleep performance data and more, providing researchers with the biometric data from those metrics which may be valuable to the success of the trial.

“We believe that giving volunteers an opportunity to use the WHOOP Strap 3.0 wearable device will reinforce their confidence in the trial by giving them the ability to check on several daily health data points,” commented Koshy. “This will complement the world-class clinical expertise that the healthcare professionals in the UAE are providing to the volunteers and ensure their safety and well-being throughout the trials process,” he added.

This news comes almost one month after it was announced that the Ladies Professional Golf Association (LPGA) and its European tour partner the Ladies European Tour (LET) were acquiring one thousand WHOOP smart bands to help monitor the vitals of players and personnel on tour.

“WHOOP is proud to partner with G42 Healthcare and participate in their innovative Phase III COVID-19 vaccine trial,” said Will Ahmed, WHOOP Founder & CEO. “The continuous biometric monitoring offered by WHOOP will help volunteers evaluate any changes to their health and help researchers vastly increase their understanding of the vaccine’s impact.”

Ahmed also added that he believes the partnership “represents the future of healthcare: using continuous monitoring and artificial intelligence to better understand the effect of drugs, vaccines, and other treatments.”

G42 Healthcare, a subsidiary of Abu Dhabi-based Group 42, is conducting the clinical trials of the vaccine — which began on July 16th in Abu Dhabi — in partnership with the Department of Health – Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA).

Phase III — which will last for between six and 12 months — follows two previous successful trials conducted by SinoPharm in China, and is open to individuals between 18 and 60 years of age living in the UAE and Bahrain.

(Originally posted on FindBiometrics)

Filed Under: Industry News Tagged With: Biometric, biometric data, biometric sensors, biometric wearables, biometrics, clinical trials, coronavirus, COVID-19, wearable biometrics, wearable tech

Related News & Articles

Innovation Finance Leverages Daon’s IdentityX for Customer Authentication

Zwipe Completes Prototype Power Management Chip for Biometric Solutions

WTTC Releases Safe Travel Guidelines for Attractions and Rental Industries

Primary Sidebar

Learn About Mobile ID and Aviation

Tweets

Sponsored Links

facetec logo

FaceTec’s patented, industry-leading 3D Face Authentication software anchors digital identity, creating a chain of trust from user onboarding to ongoing authentication on all modern smart devices and webcams. FaceTec’s 3D FaceMaps™ make trusted, remote identity verification finally possible. As the only technology backed by a persistent spoof bounty program and NIST/iBeta Certified Liveness Detection, FaceTec is the global standard for Liveness and 3D Face Matching with millions of users on six continents in financial services, border security, transportation, blockchain, e-voting, social networks, online dating and more. www.facetec.com

FACEPHI is a global leader in Facial Recognition technology and in Mobile Biometrics technologies. With a strong concentration in the financial sector, FacePhi’s product is rapidly becoming a service used by banks all over the world. Its implementation doesn’t just save money, it is also a way to attract clients and build loyalty, while increasing the security of transactions for both the customer and the business. To learn more about FacePhi, visit https://www.facephi.com/en/

Recent Posts

  • IDEMIA Brings Mobile ID to Missouri
  • Selfie-based Age Verification Emerges as Important New Digital Identity Market
  • Aiming to Extend Digital ID Beyond Air Travel, Onfido Acquires Airside
  • BIPA Plaintiff Drops Case After Reviewing FaceTec’s Privacy-focused Architecture
  • Apple Mobile Driver’s License Arrives in Georgia

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives
  • CCPA: Do not sell my personal info.

Follow Us

Copyright © 2023 MobileIDWorld